This clinical study aimed to explore the MRI features of patients with anti-NXP2 antibody and their relationship with clinical manifestations and prognosis, which will help clinicians fully understand the value of MRI examination in this particular subtype DM. The gene discussed is MORC3; the disease is dermatomyositis.